Lorem ipsum dolor sit amet

Lorem ipsum dolor sit amet consectetur. Integer eget magna mollis eleifend. Ullamcorper eu mauris luctus amet nullam. Feugiat mi libero lacus in ac magna turpis viverra.

Subscribe to news

We are excited to keep you updated with news tailored to your preferences.

By subscribing to one or more streams, you'll receive information relevant to the areas you've selected. If you ever wish to update your preferences, you can do so at any time.

Latest news

Beryl Elites: Interview with Capital Markets Advisor, Sanjeev Srivastava

Capital Markets Advisor, Sanjeev Srivastava, interviewed by Maxine Hoover
Read more

Beryl Elites: What is Artificial Evolution - an interview with CEO Heltzen

CEO Heltzen interviewed by Maxine Hoover at the Beryl Elites’ Investment Conference in New York City
Read more

International Business Times: AI meets enzymes - eXoZymes enables high-yield production of compounds previously impossible to make

IBT: AI meets enzymes
Read more

Beryl Elites: AI's Billion-dollar Bet on Life Sciences - From Drug Discovery to Patient Impact (panel)

CEO Michael Heltzen at the Beryl Elite's 'AI in Life Sciences' panel
Read more